| CEO: | Stuart Ashman |
| CFO: | Manprit Singh Randhawa |
| Executive Director: | Simon Hewitson |
| Group Finance Director: | Emily Bertram |
| Independent Non-Executive Director: | Catherine Denise Prescott |
| Non-Executive Chairman: | Martin Braddock Hunt |
| Non-Executive Dir: | Danielle Bekker |
| Address: | The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, United Kingdom, NE4 5TF |
| Phone: | +44 191 495 7325 |
| Website: | http://www.skinbiotherapeutics.com |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB00BF33H870 |
| Currency | UK Pounds |
| Share Price | 15.50p |
| Change Today | -2.00p |
| % Change | -11.43 % |
| 52 Week High | 26.10p |
| 52 Week Low | 13.63p |
| Volume | 9,058,367 |
| Shares Issued | 258.78m |
| Market Cap | £40.11m |
| Beta | 0.20 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 12:06 | 3,963,408 @ 14.65p |
| 17:05 | 67,000 @ 15.50p |
| 16:40 | 1,400,000 @ 15.55p |
| 16:39 | 18,000 @ 15.58p |
| 16:35 | 47,113 @ 15.50p |
| CEO | Stuart Ashman |
| CFO | Manprit Singh Randhawa |
You are here: research